Pacific Edge Limited (PFGTF)
USD 0.08
(-28.57%)
USD 0.08
(-28.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 4.07 Million NZD | 233.31% |
| 2023 | 764.6 Thousand NZD | -42.64% |
| 2022 | 1.33 Million NZD | -33.86% |
| 2021 | 2.01 Million NZD | 118.78% |
| 2020 | 921.28 Thousand NZD | 996.77% |
| 2019 | 84 Thousand USD | -15.15% |
| 2018 | 99 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - NZD | 0.0% |
| 2014 | - NZD | 0.0% |
| 2013 | - NZD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.77 Million USD | 98.8% |
| 2024 Q4 | 4.44 Million USD | 45.0% |
| 2024 Q1 | 542.59 Thousand USD | -27.66% |
| 2024 FY | 4.07 Million NZD | 432.69% |
| 2024 Q2 | 529.88 Thousand USD | 59.84% |
| 2023 Q3 | 260.98 Thousand USD | -29.74% |
| 2023 FY | 764.6 Thousand NZD | -42.64% |
| 2023 Q4 | 764.6 Thousand NZD | 192.97% |
| 2023 Q2 | 371.44 Thousand USD | 0.0% |
| 2022 FY | 1.33 Million NZD | -33.86% |
| 2022 Q2 | 1.61 Million USD | 0.0% |
| 2022 Q4 | 1.33 Million USD | 0.0% |
| 2021 Q4 | 2.01 Million USD | 0.0% |
| 2021 FY | 2.01 Million NZD | 118.78% |
| 2021 Q2 | 2.89 Million USD | 0.0% |
| 2020 Q4 | 921.28 Thousand USD | 0.0% |
| 2020 FY | 921.28 Thousand NZD | 996.77% |
| 2020 Q2 | 941.2 Thousand USD | 0.0% |
| 2019 FY | 84 Thousand USD | -15.15% |
| 2018 FY | 99 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2014 FY | - NZD | 0.0% |
| 2013 FY | - NZD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -81.83% |
| Arrayit Corporation | 1.07 Million USD | -277.771% |
| Atlantic International Corp. | 2.93 Million USD | -38.987% |
| Biocept, Inc. | 12.1 Million USD | 66.364% |
| Bioqual, Inc. | 3.58 Million USD | -13.549% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -5509.111% |
| DermTech, Inc. | 54.39 Million USD | 92.512% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.137% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 15.742% |
| iMD Companies, Inc. | 1.12 Million USD | -263.612% |
| IDenta Corp. | 789.14 Thousand USD | -416.128% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 63.608% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -9189.543% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 49.372% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -6.459% |
| NovelStem International Corp. | 3.57 Million USD | -13.943% |
| Optigenex Inc. | 8.94 Million USD | 54.444% |
| PharmChem, Inc. | 77.35 Thousand USD | -5165.471% |
| Proteome Sciences plc | 17.15 Million USD | 76.256% |
| Response Genetics, Inc | 6.37 Million USD | 36.09% |
| Rennova Health, Inc. | 15.32 Million USD | 73.43% |
| RushNet, Inc. | 4.82 Million USD | 15.552% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -1867.31% |
| Stella Diagnostics Inc. | 6.2 Million USD | 34.314% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -126.267% |
| Todos Medical Ltd. | 38.34 Million USD | 89.379% |